We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mouse Model Study Supports Sexual Transmission of Zikavirus Infection

By LabMedica International staff writers
Posted on 26 Apr 2016
Print article
Image: A transmission electron micrograph (TEM) image of the Zikavirus (red disks) (Photo courtesy of the CDC).
Image: A transmission electron micrograph (TEM) image of the Zikavirus (red disks) (Photo courtesy of the CDC).
A newly established mouse model, which is expected to accelerate efforts to develop a vaccine to protect against Zikavirus (ZIKV) infection, revealed high levels of the virus in the testes of the animals, a finding that supports the possible sexual transmission of the disease.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) used wild-type (WT) C57BL/6 mice, as well as a large panel of immune-deficient transgenic mice together with several different strains of ZIKV including a contemporary clinical isolate. In this study, the mice were infected via the skin in a manner that mimicked the bite of the mosquito vector of the disease.

The investigators reported in the April 5, 2016, online edition of the journal Cell Host & Microbe that whereas four- to six-week-old WT mice did not develop clinically apparent disease, mice lacking interferon alpha/beta (IFN-alpha/beta) signaling (genetically engineered triple knockout [TKO] mice) succumbed to infection with all the different ZIKV strains. Viral burden analysis revealed that mice lacking the interferon receptor (Ifnar1−/− mutants), but not WT mice, sustained high levels of ZIKV in all tissues tested, including serum, spleen, brain, spinal cord, and testes. The testes of Ifnar1−/− mice had the highest viral loads, which is relevant to the possible sexual transmission of ZIKV.

"Now that we know the mice can be vulnerable to Zika infection, we can use the animals to test vaccines and therapeutics - and some of those studies are already underway - as well as to understand the pathogenesis of the virus," said senior author Dr. Michael Diamond, professor of medicine at Washington University School of Medicine.

"We looked for evidence of Zika in the mouse testes mostly as an afterthought, due to mounting evidence of sexual transmission and were surprised that viral levels were the highest we saw in any tissue," said Dr. Diamond. "We are now doing subsequent tests to determine how long those viral levels are sustained, which could help us estimate the length of time Zika can be transmitted sexually."

Related Links:
Washington University School of Medicine
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.